Myomo (MYO) Revenue Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.59% |
| Jun 30, 2025 | 28.34% |
| Mar 31, 2025 | 161.88% |
| Dec 31, 2024 | 153.73% |
| Sep 30, 2024 | 81.27% |
| Jun 30, 2024 | 26.22% |
| Mar 31, 2024 | 8.93% |
| Dec 31, 2023 | 17.69% |
| Sep 30, 2023 | 28.01% |
| Jun 30, 2023 | 62.02% |
| Mar 31, 2023 | -10.89% |
| Dec 31, 2022 | 0.25% |
| Sep 30, 2022 | -9.48% |
| Jun 30, 2022 | 18.47% |
| Mar 31, 2022 | 65.54% |
| Dec 31, 2021 | 6.38% |
| Sep 30, 2021 | 127.54% |
| Jun 30, 2021 | 261.56% |
| Mar 31, 2021 | 131.76% |
| Dec 31, 2020 | 149.23% |
| Sep 30, 2020 | 217.61% |
| Jun 30, 2020 | -2.47% |
| Mar 31, 2020 | 21.45% |
| Dec 31, 2019 | 70.95% |
| Sep 30, 2019 | -0.39% |
| Jun 30, 2019 | 39.21% |
| Mar 31, 2019 | 165.05% |
| Dec 31, 2018 | 1,045.77% |
| Sep 30, 2018 | 24.65% |
| Jun 30, 2018 | 106.20% |
| Mar 31, 2018 | 1,592.86% |
| Dec 31, 2017 | -82.67% |
| Sep 30, 2017 | 165.23% |
| Jun 30, 2017 | 20.71% |